These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 17683826)

  • 41. Functionalized PLA polymers to control loading and/or release properties of drug-loaded nanoparticles.
    Thauvin C; Schwarz B; Delie F; Allémann E
    Int J Pharm; 2018 Sep; 548(2):771-777. PubMed ID: 29104059
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles.
    Wischke C; Schwendeman SP
    Int J Pharm; 2008 Dec; 364(2):298-327. PubMed ID: 18621492
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Amphotericin B-loaded polymeric nanoparticles: formulation optimization by factorial design.
    Carraro TC; Khalil NM; Mainardes RM
    Pharm Dev Technol; 2016 Mar; 21(2):140-6. PubMed ID: 25384838
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PEGylation strategies for active targeting of PLA/PLGA nanoparticles.
    Betancourt T; Byrne JD; Sunaryo N; Crowder SW; Kadapakkam M; Patel S; Casciato S; Brannon-Peppas L
    J Biomed Mater Res A; 2009 Oct; 91(1):263-76. PubMed ID: 18980197
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preparation of poly(lactic acid) (PLA) and poly(ethylene oxide) (PEO) nanoparticles as carriers for gene delivery.
    Csaba NS; Sánchez A; Alonso MJ
    Cold Spring Harb Protoc; 2010 Aug; 2010(8):pdb.prot5468. PubMed ID: 20679377
    [No Abstract]   [Full Text] [Related]  

  • 46. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment.
    Feng SS; Zeng W; Teng Lim Y; Zhao L; Yin Win K; Oakley R; Hin Teoh S; Hang Lee RC; Pan S
    Nanomedicine (Lond); 2007 Jun; 2(3):333-44. PubMed ID: 17716178
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PHEA-PLA biocompatible nanoparticles by technique of solvent evaporation from multiple emulsions.
    Cavallaro G; Craparo EF; Sardo C; Lamberti G; Barba AA; Dalmoro A
    Int J Pharm; 2015 Nov; 495(2):719-27. PubMed ID: 26410757
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.
    Chan JM; Zhang L; Yuet KP; Liao G; Rhee JW; Langer R; Farokhzad OC
    Biomaterials; 2009 Mar; 30(8):1627-34. PubMed ID: 19111339
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monodisperse PLA/PLGA nanoparticle fabrication through a surfactant-free route.
    Liang R; Zhu J
    J Control Release; 2011 Nov; 152 Suppl 1():e129-31. PubMed ID: 22195799
    [No Abstract]   [Full Text] [Related]  

  • 50. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
    Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X
    Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biodegradable polymersomes as efficient nanocarriers for controlled paclitaxel delivery.
    Lee JS; Feijen J
    J Control Release; 2010 Nov; 148(1):e15-6. PubMed ID: 21529596
    [No Abstract]   [Full Text] [Related]  

  • 52. Biodegradable polymers for ocular drug delivery.
    Kimura H; Ogura Y
    Ophthalmologica; 2001; 215(3):143-55. PubMed ID: 11340382
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gas-generating TPGS-PLGA microspheres loaded with nanoparticles (NIMPS) for co-delivery of minicircle DNA and anti-tumoral drugs.
    Gaspar VM; Moreira AF; Costa EC; Queiroz JA; Sousa F; Pichon C; Correia IJ
    Colloids Surf B Biointerfaces; 2015 Oct; 134():287-94. PubMed ID: 26209779
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapeutic effect of in vivo sustained estradiol release from poly (lactide-co-glycolide) microspheres on bone mineral density of osteoporosis rats.
    Otsuka M; Uenodan H; Matsuda Y; Mogi T; Ohshima H; Makino K
    Biomed Mater Eng; 2002; 12(2):157-67. PubMed ID: 12122239
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PLGA:poloxamer and PLGA:poloxamine blend nanostructures as carriers for nasal gene delivery.
    Csaba N; Sánchez A; Alonso MJ
    J Control Release; 2006 Jun; 113(2):164-72. PubMed ID: 16759732
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic effect of stealth-type polymeric nanoparticles with encapsulated betamethasone phosphate on experimental autoimmune uveoretinitis.
    Sakai T; Ishihara T; Higaki M; Akiyama G; Tsuneoka H
    Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1516-21. PubMed ID: 21178146
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preparation and evaluation of biodegradable films containing the potent osteogenic compound BFB0261 for localized delivery.
    Umeki N; Sato T; Harada M; Takeda J; Saito S; Iwao Y; Itai S
    Int J Pharm; 2011 Feb; 404(1-2):10-8. PubMed ID: 21047548
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A novel hybrid delivery system: polymer-oil nanostructured carrier for controlled delivery of highly lipophilic drug all-trans-retinoic acid (ATRA).
    Narvekar M; Xue HY; Wong HL
    Int J Pharm; 2012 Oct; 436(1-2):721-31. PubMed ID: 22850294
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prolonged analgesic effect of PLGA-encapsulated bee venom on formalin-induced pain in rats.
    Jeong I; Kim BS; Lee H; Lee KM; Shim I; Kang SK; Yin CS; Hahm DH
    Int J Pharm; 2009 Oct; 380(1-2):62-6. PubMed ID: 19577620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.